Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NanoViricides, a developer of nanomaterials, is set to lease a portion of Inno-Haven's 18,000ft² light industrial building located in Shelton.
Subscribe to our email newsletter
NanoViricides anticipates that it will be using the space in the near future for laboratory facilities and cGMP production of its nanoviricides drug candidates against various viral diseases.
It is working with various firms capable to built cGMP manufacturing at this facility in a timely manner.
NanoViricides CEO Eugene Seymour said they believe they will be achieving the cGMP manufacturing and lab space they need without capital expenditure from the company’s current cash reserves.
"We are making progress in clearing a major hurdle in our path towards FDA submissions and human clinical development of our drug candidates," Seymour said.
NanoViricides is developing the pre-IND application for clinical candidate for Influenza.